Effects of esketamine on postpartum depression and postoperative epidural analgesia in women after cesarean section

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052708

Enrollment

Unknown

Registered

2021-11-03

Start date

2021-11-15

Completion date

Unknown

Last updated

2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

experimental group:esketamine

control group:morphine

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-45 years, ASA grade 1-3, term pregnancy (greater than 37 weeks). 2. Be planned to perform cesarean section under spinal anesthesia. 3. Agree to perform patient-controlled analgesia after epidural.

Exclusion criteria

Exclusion criteria: 1. Allergy to the test drug; 2. Have a history of mental illness; 3. Have a history of chronic pain; 4. A history of domestic violence; 5. Have a history of drug abuse.

Design outcomes

Primary

Measure	Time frame
Edinburgh Postpartum Depression Scale Score;	—

Secondary

Measure	Time frame
Pain Numerical Scale Score;	—

Countries

China

Contacts

Public ContactJia Peng

The Fifth Affiliated Hospital of Sun Yat-Sen University

50253443@qq.com+86 13750005413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026